- Systems biology promotes the understanding of the blueprint of life
- Molecular biology and information technology together offer quantitative insights into complex biological processes
For the five days of the 5th ICSB, from 9 to 13 October 2004, Heidelberg will be at the hub of systems biology. At this conference more than 700 experts from 37 countries will discuss new, innovative approaches to successful biotechnological processes in medicine and industry. The event takes place under the auspices of Edelgard Bulmahn, the German Federal Minister of Education and Research.
Will life become computable? Can scientists gain a quantitative understanding and develop a computer-based representation of cells and organs with their complex responses to environmental changes, during aging or in immune responses? Will it be feasible to simulate virtual cells in silico and model high affinity pharmaceuticals to individual targets inside those cells? What is the status of international projects, and how is the German funding initiative Systems of Life – Systems Biology cross-linked in the EU and in the German research landscape? Heidelberg, the home of the German Cancer Research Center, European Molecular Biology Laboratory, and the EML Research, a renowned `pioneer location´ in systems biology, has been chosen as the seat of this conference.
This year, the ICSB presents on 9 and 10 October 2004 a two-day tutorial and workshop programme in the German Cancer Research Center (DKFZ) in Heidelberg. From 11 to 13 October, over 40 lectures will be held by distinguished experts on the topics metabolic systems, signal transduction, microbial systems biology, methods and software for systems biology, spatial models and systems biology for medicine in the Heidelberg Congress Centre. The Conference programme will be rounded off by a 330-strong poster presentation with an integrated exhibition featuring companies’ products and services.
The invited speakers include for example renowned experts, such as Prof. Denis Noble of Oxford University, UK, Prof. Bernhard O. Palsson of the University of California, San Diego, CA, USA, Prof. Marc Kirschner of Harvard Medical School in Boston, MA, USA, and Prof. Masura Tomita of Keio University in Fujisawa, Japan. |
